<DOC>
	<DOCNO>NCT01574222</DOCNO>
	<brief_summary>The purpose study determine dose vaccine give safely patient inject directly lung tumor , without serious side effect .</brief_summary>
	<brief_title>A Vaccine Trial Patients With Stage IIIB , IV , Recurrent Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Primary - determine safety , toxicity , Maximum Tolerated Dose ( MTD ) autologous dendritic cell-adenovirus chemokine ( C-C motif ) ligand 21 ( CCL21 ) vaccine administer intratumoral injection treat patient stage IIIB , IV , recurrent non-small cell lung cancer Secondary - determine biologic clinical response therapy - determine treatment-related toxicity use NCI Common Toxicity Criteria - identify maximum tolerate dose ( MTD ) - monitor patient evidence autologous dendritic cell-adenovirus CCL21 vaccine-induced cytokine antigen-specific immune response - detect immune response tumor-associated antigen vector - ass patient objective sign tumor regression ( RECIST criterion )</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Screening , physical exam , blood draw , CT scan , followup perform VA Greater Los Angeles . All interventional procedure include leukapheresis , CT guided/bronchoscopic biopsy vaccine injection perform University California Los Angeles ( UCLA ) . Adults age 21 capable give informed consent Pathologically confirm nonsmall cell lung cancer ( NSCLC ) Stage IIIB , IV recurrent disease Progressive disease despite one prior chemotherapy regimens standard care OR patient refusal standard chemotherapy Measurable metastatic disease RECIST guideline Patients major endobronchial lesion segmental , lobar , mainstem bronchus complete obstruction airway may eligible bronchoscopic injection provide evidence respiratory failure ( define SaO2 least 90 % room air , PCO2 less , equal 45 mm Hg , FEV1 great 1.0L ) Patients endobronchial lesion segmental bronchus variable stenosis ( completely obstruct ) amenable standard palliative airway treatment ( i.e. , laser stenting ) may eligible bronchoscopic injection indication respiratory failure define Patient bullous disease may undergo CTguided transthoracic injection provide targeted tumor intend needle path without cross bulla ECOG performance status 02 BUN less equal 40 OR serum creatinine le 2 Serum total bilirubin less equal 1.5 OR serum transaminase less equal 2.5 time upper limit normal ( ULN ) Negative pregnancy test ( applicable ) Fertile patient must use effective contraception More 14 day since prior acute therapy viral , bacterial , fungal infection More 30 day since prior concurrent corticosteroid More 15 day since prior radiotherapy More 30 day since prior chemotherapy , noncytotoxic investigational agent Active CNS metastasis ( i.e. , progression CNS disease past 30 day without intervention ) Evidence coagulopathy , define PT and/or PTT 1.5 time ULN platelet equal 100,000/mm3 . Evidence leukoplakia , define absolute neutrophil count equal 1,500/mm3 Evidence respiratory failure ( define SaO2 le 90 % room air , PCO2 45 mm Hg , FEV1 le 1.0 L NYHA class IIIIV within past year Myocardial infarction within past year Comorbid disease medical condition would impair ability patient receive comply study protocol Acute viral , bacterial fungal infection require specific therapy HIV positive Hypersensitivity reagent use study Signs sensitivity acute adenoviral infection ( i.e. , conjunctivitis document adenoviral upper respiratory infection ) Pregnant nursing Prior organ allograft</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Stages IIIB , IV , recurrent NSCLC</keyword>
	<keyword>Carcinoma , Non-small cell lung</keyword>
	<keyword>Lung Neoplasms</keyword>
	<keyword>Carcinoma , Bronchogenic</keyword>
	<keyword>Thoracic Neoplasms</keyword>
	<keyword>Neoplasms Site</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Lung Diseases</keyword>
</DOC>